Non-Research-Related Physician-Industry Relationships of Radiologists in the United States.

[1]  H. Harvey,et al.  Bringing transparency to physician-industry relationships: what the Physician Payment Sunshine Act will mean for interventional radiologists. , 2013, Journal of vascular and interventional radiology : JVIR.

[2]  G. Pham-Kanter,et al.  Brightening Up: The Effect of the Physician Payment Sunshine Act on Existing Regulation of Pharmaceutical Marketing , 2013, Journal of Law, Medicine & Ethics.

[3]  S. Chimonas,et al.  Academic medical centers' conflict of interest policies. , 2010, JAMA.

[4]  S. Chimonas,et al.  Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. , 2010, Health services research.

[5]  David B. Resnik,et al.  Conflict of Interest in Medical Research, Education, and Practice , 2010, Environmental Health Perspectives.

[6]  E. Campbell.  Doctors and drug companies--scrutinizing influential relationships. , 2007, The New England journal of medicine.

[7]  David Blumenthal,et al.  A national survey of physician-industry relationships. , 2007, The New England journal of medicine.

[8]  W P McKinney,et al.  Pharmaceutical representatives in academic medical centers , 1990, Journal of General Internal Medicine.

[9]  E. Campbell,et al.  Financial relationships between institutional review board members and industry. , 2006, The New England journal of medicine.

[10]  A. Wazana,et al.  Physicians and the pharmaceutical industry: is a gift ever just a gift? , 2000, JAMA.

[11]  Thomas Pasko,et al.  Physician Characteristics and Distribution in the Us: 1999 , 1998 .

[12]  J. Berlin,et al.  When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? , 1996, Academic medicine : journal of the Association of American Medical Colleges.

[13]  M. Chren,et al.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. , 1994, JAMA.

[14]  M. Bowman,et al.  Changes in drug prescribing patterns related to commercial company funding of continuing medical education. , 1988, The Journal of continuing education in the health professions.

[15]  R. Arthur.  Academic medical centers. , 1988, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.

[16]  E. R. Peay,et al.  The role of commercial sources in the adoption of a new drug. , 1988, Social science & medicine.